marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Voyager Therapeutics Balance Sheet 2011-2024 | VYGR
Annual Balance Sheet Voyager Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-48.5 M | -75.8 M | -73.3 M | - | -51.9 M | -46.9 M | -31.5 M | -36.6 M | -31.3 M | -7.04 M | 2.79 M | - | - |
Long Term Debt |
17.1 M | 20.3 M | 38.6 M | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
3.2 M | 2.83 M | 5.57 M | 4.2 M | 3.19 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 179 M | 98.9 M | 34.5 M | 39.8 M | 36.5 M | 7.87 M | - | - | - |
Total Current Liabilities |
64.5 M | 72.6 M | 51 M | 26.8 M | 76 M | 31.7 M | 15.9 M | 13.8 M | 23.9 M | - | - | - | - |
Total Liabilities |
115 M | 100 M | 98.8 M | 107 M | 255 M | 131 M | 50.4 M | 53.6 M | 60.4 M | 10.3 M | 3.98 M | - | - |
Deferred Revenue |
42.9 M | 59.4 M | 33.9 M | 7.73 M | 47.2 M | 20.8 M | 3.38 M | 6.76 M | 19.6 M | - | - | - | - |
Retained Earnings |
-261 M | -394 M | -347 M | - | -313 M | -269 M | -161 M | -90 M | -49.8 M | -20.8 M | -3.83 M | - | - |
Total Assets |
351 M | 159 M | 194 M | 262 M | 355 M | 177 M | 184 M | 190 M | 229 M | 11.5 M | 149 K | - | - |
Cash and Cash Equivalents |
68.8 M | 99 M | 117 M | 104 M | 86 M | 46.9 M | 31.5 M | 36.6 M | 31.3 M | 7.04 M | 135 K | - | - |
Book Value |
236 M | 59 M | 95.1 M | 154 M | 99.5 M | 46.4 M | 134 M | 136 M | 169 M | 1.15 M | -3.83 M | - | - |
Total Shareholders Equity |
236 M | 59 M | 95.1 M | 154 M | 99.5 M | 46.4 M | 134 M | 136 M | 169 M | -20.8 M | -3.83 M | - | - |
All numbers in USD currency
Quarterly Balance Sheet Voyager Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
38.4 M | 40.2 M | 42 M | 17.1 M | 17.9 M | 18.7 M | 19.5 M | 20.3 M | 21 M | - | 37.1 M | 38.6 M | 40 M | 40.8 M | 42.1 M | 43.4 M | 43.4 M | 43.4 M | 43.4 M | 31 M | 31 M | 31 M | 31 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
95.7 M | 101 M | 129 M | 115 M | 118 M | 117 M | 119 M | 100 M | 103 M | - | 148 M | 98.8 M | 97.4 M | 98.2 M | 102 M | 107 M | 107 M | 107 M | 107 M | 255 M | 255 M | 255 M | 255 M | 131 M | 131 M | 131 M | 131 M | 50.4 M | 50.4 M | 50.4 M | 50.4 M | 53.6 M | 53.6 M | 53.6 M | 53.6 M | 60.4 M | 60.4 M | 60.4 M | 60.4 M | 10.3 M | 10.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
22.6 M | 20.5 M | 51.4 M | 42.9 M | 44.3 M | 31.7 M | 5.68 M | 59.4 M | 56.6 M | - | 87 M | 33.9 M | 9.54 M | 8.07 M | 6.44 M | 7.73 M | 7.73 M | 7.73 M | 7.73 M | 47.2 M | 47.2 M | 47.2 M | 47.2 M | 20.8 M | 20.8 M | 20.8 M | 20.8 M | 3.38 M | 9.54 M | 4.22 M | 4.91 M | 6.76 M | 6.76 M | 6.76 M | 6.76 M | 19.6 M | 19.6 M | 19.6 M | 19.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-292 M | -283 M | -273 M | -261 M | -318 M | -292 M | -269 M | -394 M | -370 M | - | -368 M | -347 M | -353 M | -328 M | -298 M | -276 M | -276 M | -276 M | -276 M | -313 M | -313 M | -313 M | -313 M | -269 M | -269 M | -269 M | -269 M | -161 M | -161 M | -161 M | -161 M | -90 M | -90 M | -90 M | -90 M | -49.8 M | -49.8 M | -49.8 M | -49.8 M | -20.8 M | -20.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
426 M | 436 M | 470 M | 351 M | 295 M | 316 M | 336 M | 159 M | 182 M | - | 224 M | 194 M | 185 M | 209 M | 238 M | 262 M | 262 M | 262 M | 262 M | 355 M | 355 M | 355 M | 355 M | 177 M | 177 M | 177 M | 177 M | 184 M | 184 M | 184 M | 184 M | 190 M | 190 M | 190 M | 190 M | 229 M | 229 M | 229 M | 229 M | 11.5 M | 11.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
113 M | 76.1 M | 143 M | 68.8 M | 66.9 M | 246 M | 268 M | 99 M | 98.4 M | 79.8 M | 132 M | 117 M | 113 M | 118 M | 118 M | 104 M | 104 M | 104 M | 104 M | 86 M | 86 M | 86 M | 86 M | 46.9 M | 46.9 M | 46.9 M | 46.9 M | 31.5 M | 31.5 M | 31.5 M | 31.5 M | 36.6 M | 36.6 M | 36.6 M | 36.6 M | 31.3 M | 31.3 M | 31.3 M | 31.3 M | 7.04 M | 7.04 M | - | - | 135 K | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
330 M | 335 M | 341 M | 236 M | 176 M | 199 M | 217 M | 59 M | 79.8 M | - | 75.9 M | 95.1 M | 87.4 M | 111 M | 136 M | 154 M | 154 M | 154 M | 154 M | 99.5 M | 99.5 M | 99.5 M | 99.5 M | 46.4 M | 46.4 M | 46.4 M | 46.4 M | 134 M | 134 M | 134 M | 134 M | 136 M | 136 M | 136 M | 136 M | 169 M | 169 M | 169 M | 169 M | 1.15 M | 1.15 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
330 M | 335 M | 341 M | 236 M | 176 M | 199 M | 217 M | 59 M | 79.8 M | 60.1 M | 75.9 M | 95.1 M | 87.4 M | 111 M | 136 M | 154 M | 154 M | 154 M | 154 M | 99.5 M | 99.5 M | 99.5 M | 99.5 M | 46.4 M | 46.4 M | 46.4 M | 46.4 M | 134 M | 134 M | 134 M | 134 M | 136 M | 136 M | 136 M | 136 M | 169 M | 169 M | 169 M | 169 M | -20.8 M | -20.8 M | - | - | -3.83 M | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency